RCE ASX Chart
Snapshot
Recce Pharmaceuticals Ltd (RCE)is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral pathogens. Recce's anti-infective pipeline includes three patented, broad-spectrum, synthetic polymer anti-infectives are RECCE 327, RECCE 435 and RECCE 529.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -25.66% |
vs ASX 200 (1yr) | -34.04% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | NXS / BD1 / MAP |
EPS | -$0.064 |
DPS | $0.00 |
Book Value Per Share | -$0.013 |
Broker Consensus
Please see the Broker Consensus page.
Top Market Index News
Announcements
Corporate Overview
Corporate Details
Head Office | Sydney NSW 2000 |
Website | www.recce.com.au |
Registry | Automic Group |
Auditor | BDO Audit (WA) Pty Ltd |
Date Listed | 15 Jan 2016 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
29/08/2024 | Report (Prelim) |
27/09/2024 | Report (Annual) |
25/02/2025 | Report (Interim) |
Former Company Names
- Recce Limited (RCE), 16/01/2018
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
RCE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of RCE directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
FIL Limited | 18/09/2023 | 15,144,466 | 7.69 |
Graham John Hamilton Melrose & Olga Mary Melrose | 18/09/2023 | 37,028,311 | 18.81 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
18-09-23 | FIL Limited and the entities | 15,144,466 | -- | 7.69 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.625 | 30 June |
2022 | $0.890 | 30 June |
2021 | $0.930 | 30 June |
2020 | $0.670 | 30 June |
2019 | $0.215 | 28 June |
2018 | $0.190 | 29 June |
2017 | $0.205 | 28 June |
2016 | $0.250 | 28 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.